CN104126666A - Blended milk containing antarctic krill oil - Google Patents
Blended milk containing antarctic krill oil Download PDFInfo
- Publication number
- CN104126666A CN104126666A CN201410366020.0A CN201410366020A CN104126666A CN 104126666 A CN104126666 A CN 104126666A CN 201410366020 A CN201410366020 A CN 201410366020A CN 104126666 A CN104126666 A CN 104126666A
- Authority
- CN
- China
- Prior art keywords
- krill oil
- antarctic krill
- modulation breast
- milk
- mass parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention relates to blended milk containing antarctic krill oil. The blended milk is prepared by adding 0.001 to 2 parts of antarctic krill oil by mass to 70 to 99.99 parts of raw milk by mass and subjecting the mixture to emulsification, homogenization and sterilization. The krill oil is added to the raw milk as an omega3 fatty acid enhancer. The krill oil itself has unique emulsibility, so that no emulsifier needs to add or only little emulsifier needs to add. The antarctic krill oil is rich in omega3 fatty acids, namely eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), and contains phospholipids, astaxanthin and other natural antioxidants. Besides, the rich unsaturated fatty acids in the antarctic krill oil are fatty acids combined in a phospholipid mode, which have a much higher human body absorption rate than fish oil or algae oil. Long-term consumption of the blended milk provides functions of protecting cardio and cerebral vessels, tonifying brain and developing intelligence, delaying senility and improving immunity, and the blended milk is especially suitable for children, brainworkers and middle-aged and elderly people.
Description
Technical field
The present invention relates to a kind of modulation breast that contains antarctic krill oil.
Technical background
Antarctic krill oil is derived from krill, and krill is lived in pollution-free waters, frigid zone, the South Pole.Antarctic krill oil is rich in Omega-3 polyunsaturated fatty acid, phosphatide, the astaxanthin isoreactivity material taking eicosapentaenoic acid (EPA) and DHA (DHA) as representative, is precious health products raw material.Its unrighted acid be with phosphatide kenel in conjunction with omega3 (EPA, DHA), make omega3 polyunsaturated fatty acid more stable, and be easier to be absorbed by the body.
At present, relevant Omega 3 products on market are mainly derived from fish oil and algal oil, EPA and DHA in fish oil and algae oil, and they mainly exist with fatty-acid ethyl ester or triglycerides form; And EPA and DHA in antarctic krill oil mainly exist with phospholipid form, phosphatide more benefits the absorption of human body.Research is found, utilizes antarctic krill oil to test obese people, finds that krill oil can increase the concentration of EPA and DHA in obese people blood.In the human plasma of taking continuously krill oil (2g/d) surrounding, the concentration amplification of EPA and DHA, apparently higher than taking the amplification of herring oil (2g/d) and taking the amplification of olive oil (2g/d), has illustrated that krill oil has good absorbability in human body.And after measured, krill oil does not produce any toxic and side effect.
Antarctic krill oil has proved following health-care efficacy: 1 reduces cholesterol, prevention cerebral hemorrhage, cerebral thrombus;
2 reduce blood viscosities, stimulate circulation, preventing hypertension; 3 brain tonic and intelligence developments, active thinking, prevention senile dementia;
4 protection brain nervous cells are promoted memory; 5 antifatigues, improve immunity; 6 alleviate gout and rheumatoid arthritis; 7 is anti-oxidant, delays senility; 8 alleviate the malaise symptoms before gynecologic menstrual;
In product of the present invention, described antarctic krill oil is taking krill as raw material, obtain by dry, low-temperature extraction, the technique such as concentrated, does its quality meet Ministry of Public Health's new resource food 2013? number bulletin, wherein content of phospholipid >=40%, DHA content >=5.5%, EPA content >=15%, content astaxanthin >=50ppm.
Phosphatide
Phosphatide also claims phospholipid, Phospholipids, is the lipid that contains phosphoric acid, belongs to complex liped.The biomembranous main component of Lipid composition, is divided into glycerophosphatide and the large class of sphingomyelins two, is made up of respectively glycerine and sphingol.Phosphatide is amphiphatic molecule, and one end is the tail of hydrophilic nitrogenous or phosphorus, and the other end is the long hydrocarbyl chain of hydrophobic (oleophylic).Due to this reason, phospholipid molecule water-wet side is mutually close, and hydrophobic side is mutually close, and other molecules such as normal and protein, glycolipid, cholesterol form lipid bilayer, i.e. the structure of cell membrane jointly.It is the main component of all membranaceous structures in cell.
Phosphatide is the complex lipid of phosphoric acid.Comprise phosphoglyceride (claiming again glycerophosphate) and sphingomyelins two classes.The important component of organism, as more in the seed content of the brain of animal, liver, red blood cell and yolk etc. and plant, phosphatide is the important component of cell membrane and various organelle (mitochondria, endoplasmic reticulum, nucleus, Golgi's organs, chloroplaset etc.) film, and almost the contained whole phosphatide of cell all concentrate in biomembrane.Biomembranous numerous characteristics, as the permeability barrier as material inside and outside film, the exchange of the inside and outside material of film, information transmission, the conduction of nerve impulse etc. are all relevant with other film fat with phosphatide.The main chain of phosphoglyceride is glycerine, and the 3rd hydroxyl of glycerine be by Phosphation, and two other hydroxyl is by fatty acid esterification, and the phosphate group again micromolecular compound different from various structures is connected.Two long hydrocarbon chains (fatty acid chain) have non-polar character, and the ester bond that the 3rd hydroxyl of glycerol molecule and phosphoric acid form has polarity; So this compounds is amphipathic amphiphatic molecule.Common phosphoglyceride has phosphatid ylcholine (lecithin), phosphatidyl-ethanolamine (cephalin) etc.The main chain of sphingomyelins is sphingol (containing amino long-chain alcohol compounds), and aliphatic acid is connected to amido link on its amino, and phosphoric acid is connected on its 1-hydroxyl with ester bond.Sphingomyelins is also amphipathic amphiphatic molecule, is the abundantest sphingolipid (sphingol is the main component of sphingomyelins, therefore also belong to sphingolipid) of content in higher mammal nerve fiber.Phosphatide can synthesize and turnover rapidly in vivo.
One of phosphatide Main Function is: emulsification is decomposed too high blood fat and too high cholesterol, cleaning pigging, make blood vessel circulation smooth and easy, to be known as blood vessel street cleaner, can also make cholesterol emulsification overstocked in neutral fat and blood vessel is harmless scintilla state, and be dissolved in the water and excrete, stop superabundant fats to deposit at vascular wall simultaneously, alleviate the pressure of cardiovascular and cerebrovascular.Why phosphatide prevents and treats modern civilization diseases, and one of its basic reason is that it has powerful emulsification exactly.
Two of phosphatide Main Function: increase intelligence
Human neuronal cell line and brain cell are to be main formed cell film coated by phosphatide, and phosphatide deficiency can cause film impaired, causes hypophrenia, stress.And the acetyl containing in phosphatide enters in human body and choline binding, form acetylcholine.And the acetylcholine carrier of transmission of information between various nerve cells and brain cell exactly.Can accelerate the speed that between nerve cell and brain cell, information is transmitted, improve one's memory, prevention senile dementia.
Three of phosphatide Main Function: activating cell phosphatide is the important component part of cell membrane, is bearing the important task of the inside and outside mass exchange of cell.If the phosphatide that people consumes every day can not get supplementing, cell will, in nutritional deficiency state, lose vigor.People's liver can synthesize some phosphatide, but major part is absorbed from diet.Particularly after thirty or forty years, but the activity of phosphatide is the most effective with 25 degree left and right, and temperature exceedes after 50 degree Celsius, and phosphatide is active can major part be lost.Therefore the people of the healthy people's inferior health of my suggestion can edible phospholipid, can bring unexpected effect to you.
DHA
DHA, DHA, is commonly called as docosapentaenoic acid, is a kind of to the very important polyunsaturated fatty acid of human body, belongs to the important member in Omega-3 unrighted acid family.DHA is a kind of essential element that nervous system cell is grown and maintained, and is brain and amphiblestroid important composition composition, and in human brain cortex, content is up to 20%, proportion maximum in eye retina, account for 50%, therefore, most important to tire infant intelligence and visual acuity.
1.DHA can promote fetal brain development
DHA can optimize the constituent of fetal brain cones's phosphatide.Especially fetus is full after 5 months, as the sense of hearing to fetus, vision, sense of touch artificially stimulate, can cause that the sensorial neuron of fetal brain cortex increases more dendron, and this just needs parent to supply with the more DHA of fetus simultaneously.
2.DHA can promote the maturation of retina light sensation cell
DHA not only has material impact to fetal brain development, and the maturation of retina light sensation cell is played an important role.Pregnant woman can be rich in DHA food by absorption in the pregnancy period, is then transported to fetal brain and retina, and nerve cell maturity there is improved.
3.DHA can promote the growth of brain cell
In cerebral cortex, DHA is the Main Ingredients and Appearance of nerve conduction cell, is also the film formed Main Ingredients and Appearance of cell, most DHA can not digested by gastric juice, and directly enter blood, absorbed by the organ such as liver or brain, and EPA and linolenic acid are not absorbed by blood-brain barrier and are absorbed by brain.
4.DHA can be for treatment of cancer
Scientist's discovery, the omega-fatty acid being rich in deep-sea fish and DHA and derivative thereof can kill neuroblastoma cancer cell in body.In this research, scientist transfers in medulloblastoma DHA from nervous system, when DHA is after endocellular metabolism, then the accessory substance in cell is analyzed.Scientist has studied DHA and the impact of derivative on growth of cancer cells thereof subsequently.Result of study shows, DHA has killed all cancer cells, and the toxicity being produced by DHA derivative more can be killed cancer cell effectively than DHA itself.This shows, DHA maybe can become a kind of new treatment neuroblastoma or the novel drugs of other cancers.This research is significant to treatment cancer, and due to the important function of DHA in protection health, can develop the cancer therapy drug that a class is new future according to DHA and derivative thereof.
5.DHA can suppress inflammation
DHA can suppress the formation of inflammation precursor, so have antiinflammation.
6.DHA can reduce blood fat, prevention cardiovascular disease
DHA can reduce the formation of triglyceride in blood, cholesterol and pre-preventing thrombosis.
7.DHA can improve old man's dementia
Due to advancing age, the DHA in brain will reduce gradually, that is to say the degeneration that easily causes brain function.In fact, brain cell can constantly be grown up before two to three years old, after growing to manhood, can reduce gradually, according to investigation, in the time of 20 to 30 years old, brain cell can reduce gradually with the ratio of 100,000, even so, DHA still has the strength that makes remaining brain cell activate, improves fully memory and learning ability.
EPA
EPA is that Eicosapntemacnioc Acid is the english abbreviation of eicosapentaenoic acid, and EPA belongs to omega3 series polyunsaturated fatty acid, is that human body self can not synthesize but indispensable important nutrient, is therefore called essential fatty acid.Although leukotrienes can be converted into EPA in human body, this reacts, and speed in human body is very slow and inversion quantity is little, can not meet the needs of human body to EPA far away, therefore must from food, directly supplement.EPA has the content that helps to reduce cholesterol and triglycerides, promotes saturated fat acid metabolic in body.Thereby play reduction blood viscosity, promote blood circulation, raising is organized oxygen supply and is eliminated fatigue.Prevent that fat is in the deposition of vascular wall, the angiocardiopathies such as formation and development that prevention of arterial is atherosis, prevention cerebral thrombus, cerebral hemorrhage, hypertension.
Astaxanthin
Natural astaxanthin is that the mankind find the antioxidant that nature is the strongest up to now.It is 6000 times of ascorbic effect that its effect is identified; 1000 times of vitamin E; 10 times of natural β-carrotene; 17 times of grape pip; Luteinic 200 times; 150 times of OPC; 60 times of Q10; 200 times of Tea Polyphenols; 7 times of lycopene.
Astaxanthin health-care efficacy is as follows:
1. and the protective effect of central nervous system
Human retina and central nervous system (brain) are rich in unrighted acid, and therefore, the free radical that oxidation produces is easy to make it that peroxide injury occurs.There are some researches show; astaxanthin is easy to by blood-brain barrier and cell membrane; can effectively prevent the damage of amphiblestroid oxidation and photosensory cell; and central nervous system is especially played a protective role to brain, thereby effectively treat ischemia reperfusion injury, the central lesion such as spinal cord injury, parkinson's syndrome, Alzheimer syndrome.Especially macula retinae sex change effect is more remarkable compared with lutein.
2. ultraviolet radiation preventing
As everyone knows, ultraviolet radiation is the major reason that causes epidermis light aging and cutaneum carcinoma.Research shows, astaxanthin has special role to glutamine transaminage (transglutaminase), can in the time that skin is subject to illumination, consume putrescine, and oral astaxanthin is stronger than oral vitamin A to the inhibitory action of putrescine accumulation.Therefore, the strong anti-oxidation of astaxanthin may make it become potential bright protective agent, effectively removes the free radical that causes skin aging, and Cell protection film and mitochondrial membrane are avoided oxidative damage, for stoping skin photoage.
3. angiocardiopathy preventing
The clinical research of artery sclerosis and related cardiovascular disease shows, the oxidation of low-density lipoprotein (LDL) is to cause arteriosclerotic major reason.In human body, LDL concentration is higher, and platelet deposition makes the blood vessel obstruction VPV that attenuates in addition, and it is just larger that human body is suffered from arteriosclerotic risk.Blood middle-high density lipoprotein (HDL) has opposite effect, and it can stop arteriosclerotic generation.In blood of human body, astaxanthin is carried by VLDL (VLDL), LDL and HDL.External and clinical testing proves everyone oral 3.6mg/d astaxanthin, continuous 2 weeks, can prevent the oxidation of LDL.In addition, there is zooscopy to show, astaxanthin has in vivo remarkable rising HDL and falls effect of LDL, wherein HDL can be increased to 66.5 ± 5.1mg/dL by 49.7 original ± 3.6mg/dL, therefore infer that astaxanthin can alleviate the oxidation of apolipoprotein, can be used to prevention of arterial sclerosis, coronary heart disease and ischemic brain damage.Be different from the medicine of general reduction LDL, take 1.8,3.6,14.4 and 21.6mg astaxanthin after continuous 2 weeks every day, the time of LDL oxidation has been extended respectively 5.0%, 26.2%, 42.3% and 30.7%; Thereby can the atherosis generation of prevention of arterial.
4. strengthen immunity
Astaxanthin can significantly affect the immunologic function of animal, in the time having antigen to exist, can obviously promote splenocyte to produce the ability of antibody, strengthens the effect of T cell, stimulates the generation of immunoglobulin (Ig) in body.Astaxanthin can also partly recover the immunity system of old mouse, wherein can make IgM, IgA and IgG in Mice Body all be increased to respectively 10mol/L, shows that, at the antigen invasion initial stage, it can strengthen specific humoral immunity reaction.In addition, astaxanthin can also strengthen the ability of mouse release interleukins-I α and tumor necrosis factor α, and its effect is more much better than than beta carotene and canthaxanthin.Think thus, astaxanthin has the activity of very strong inducing cell division, has important immunoregulation effect.
5. relieving sports fatigue, strengthens human body energy metabolism
In the time of body movement, muscle can discharge free radical, if these free radicals are not processed in time by antioxidant, will produce oxidative pressure, causes the damage of DOMS or musculature.Research shows, astaxanthin can be used as the oxidative damage effect that a kind of antioxidant suppresses radical pair body.In addition, oral astaxanthin can also be strengthened aerobic metabolism, increases muscle strength and muscle tolerance, and relieving sports fatigue, alleviates the Delayed onset myalgia producing after strenuous exercise rapidly.Be mainly manifested in: 4mg/ days, can amplification muscle power 40% after 6 months.4mg/ days, can extend the time 20% of persistent movement after 2 weeks, and reduces post exercise lactic acid and pile up 28.6%.
6. the anti-infective characteristic of anti-inflammatory
Due to arthralgia and the arthritis oxidative damage that normally free radical causes.The anti-oxidation characteristics that astaxanthin is stronger contributes to suppress free radical, reduces its oxidative damage to joint.
7. suppress tumour
The research of Tanaka etc. shows, give experimental rat and the mouse astaxanthin 100～500mg/kg that feeds, can significantly suppress the initial stage canceration of chemicals induction, there is the effect of antiproliferative effect and reinforced immunological function to being exposed to epithelial cell in carcinogen, and there is dose-effect relationship in this effect.Compared with control group, Tumor incidence and the tumor size of high dose group (500mg/kg) are starkly lower than control group and low dose group.Therefore infer that astaxanthin has significant anticancer property.Astaxanthin can also be induced the transferase in liver, significantly suppresses mouse bladder cancer, rat carcinoma of mouth and colon cancer, cancer of the stomach, and its action effect is more more obvious than beta carotene.In addition, astaxanthin can also prevent the carcinogenicity of aflatoxin, and quantity and the volume effect of the tumor cell of liver to the induction of minimizing aflatoxin are good.The anticancer mechanism of astaxanthin has been considered to it and has expressed relevantly with the stability of cell membrane and protein gene, regulates cell-cell communication, thereby improve intercellular balanced capacity by changing membrane stability and gene expression quantity, maintains the normal function of cell.
8. suppress diabetic nephropathy
Diabetes patient 70% can develop into ephrosis infringement in 5 years, astaxanthin is unique material that can effectively stop diabetogenous nephrosis disease damage of finding up to now, and astaxanthin is mainly by direct protection GBM, stops the free radical producing because of hyperglycaemia to destroy basilar memebrane; In addition, can also resist the free radical of renal cells, the normal transhipment at renal tubular cell of protection glucose and phosphorus, thus preserve ATP and these important substance of sodium-potassium ATP enzyme, guarantee that renal blood flow is unaffected, reduce albuminuretic generation.Studies confirm that: 8mg astaxanthin, 8 time-of-weeks can significantly reduce urine protein 70 %.
In China, krill belongs to the not yet resource of scale development, does not also have the krill product of independent intellectual property right to appear on the market, and in China's patent protection only about the patent aspect krill oil extraction, there is not yet the relevant report of krill oil dairy products.
At present, omega 3 aliphatic acid that relevant Omega 3 on market modulates Ruzhong are main mainly with fish oil and algae oil, and antarctic krill oil is from marine site, the free of contamination South Pole, its unrighted acid is with the combination of phosphatide kenel, also better than fish oil and algae oil human absorptivity good stability, stability.It is natural, green and healthy that modern consumer is more and more advocated, and therefore, the nutrition modulation breast that adds antarctic krill oil will have more wide development space.
Summary of the invention
The object of this invention is to provide a kind of modulation breast that contains antarctic krill oil.
The present invention includes following aspect:
1. a modulation breast that contains antarctic krill oil, comprises in its composition of raw materials:
Lactogenesis 70～99.999 mass parts
Antarctic krill oil 0.001～2 mass parts
2. refer to a kind of of common cow's milk or sheep Ruzhong or two kinds according to the lactogenesis described in item 1, comprise full-cream, degreasing and half degreasing; Or distribute the recombined milk forming by other components of milk powder, cream, protein hydrolysate, whey powder or raw milk, raw sheep breast.
3. according to the modulation breast that contains antarctic krill oil described in item 1-2, it is characterized in that: described modulation breast contains stabilizing agent 0～0.3 mass parts, be selected from the mixture of ascorbic acid, sodium ascorbate, tertiary sodium phosphate, sodium dihydrogen phosphate, natrium citricum, potassium citrate, potash, saleratus, sodium carbonate, carragheen, Arabic gum, guar gum, pectin, sodium alginate, agar, microcrystalline cellulose, locust bean gum, ratio is arbitrary proportion.
4. according to the modulation breast that contains antarctic krill oil described in item 1-3, it is characterized in that: described modulation breast contains emulsifying agent 0～0.3 mass parts, the mixture that is selected from sucrose acid fatty acid ester, mono-fatty acid glyceride, sorbose alcohol ester, soybean lecithin, lauric monoglyceride, methyl glycol fatty acid ester, ratio is arbitrary proportion.Because containing a large amount of phosphatide in krill oil, self has emulsibility, therefore can add in addition emulsifying agent, or can be according to the characteristic of lactogenesis or the characteristic of adding other nutriments, takes the circumstances into consideration to add.
5. according to the modulation breast that contains antarctic krill oil described in item 1-4, it is characterized in that: described modulation breast contains sweetener 0～10 mass parts, be selected from the mixtures such as glucose, fructose, sucrose, maltose, lactose, Sucralose, acesulfame-K, saccharin sodium, antierythrite, xylitol, D-sorbite, mannitol, maltitol, hydroxyl isomaltulose, its ratio is arbitrary proportion.
6. according to the modulation breast that contains antarctic krill oil described in item 1-5; it is characterized in that: institute tell modulation breast also contain other nutrient 0～1 mass parts; be selected from the mixture in VitAVitE, vitamin D, Taurine, FOS, galactooligosaccharide, oligoisomaltose, lutein, lutein ester, beta carotene, sterol, sterol ester, mineral salt, its ratio is arbitrary proportion.
7. according to the modulation breast that contains antarctic krill oil described in claim 1-6, it is characterized in that: institute tells modulation breast and also contains flavoring essence 0～0.3 mass parts, and the flavoring essence of telling can be natural essence, natural equivalent essence or artificial essence.Such as: one or more mixtures with arbitrary proportion composition such as fruity essence, milk-taste essence, flower taste essence, tea essence.
Only otherwise affect object of the present invention, the production of modulation breast of the present invention can adopt the common process of any the art.
Product of the present invention has been broken through mechanism and the ratio of original flavored milk; the new varieties of product are increased; unrighted acid, phosphatide are supplemented; for improving memory and protecting cardiovascular and cerebrovascular all to there is benefit; and the high-efficiency antioxidant agent astaxanthin containing in krill oil, has the effects such as resisting oxidation and delaying senility; make product nutrition abundanter, met the nutritional need of modern consumer.
In addition, modulation breast of the present invention, because can also add other nutriment, makes product nutritional need clearly demarcated, can meet the demand of different crowd.Product of the present invention can meet many-sided crowds' such as children and adolescents, working clan, the elderly demand, has the very strong market demand.
Detailed description of the invention
With specific embodiment, content of the present invention is described further the content that embodiment does not limit the present invention in any way below.
Embodiment 1
Embodiment 2
Embodiment 3
Embodiment 4
Embodiment 5
Embodiment 6
Embodiment 7
Embodiment 8
Claims (7)
1. contain a modulation breast for antarctic krill oil, it is characterized in that comprising in its composition of raw materials:
Antarctic krill oil 0.001～2 mass parts,
Lactogenesis 70～99.99 mass parts.
2. the modulation breast that contains antarctic krill oil according to claim 1, is characterized in that: lactogenesis refers to a kind of of common cow's milk or sheep Ruzhong or two kinds, comprises full-cream, degreasing and half degreasing; Or distribute the recombined milk forming by other components of milk powder, cream, protein hydrolysate, whey powder or raw milk, raw sheep breast.
3. according to the modulation breast that contains antarctic krill oil described in claim 1-2, it is characterized in that: described modulation breast contains stabilizing agent 0～0.3 mass parts, be selected from the mixture of ascorbic acid, sodium ascorbate, tertiary sodium phosphate, sodium dihydrogen phosphate, natrium citricum, potassium citrate, potash, saleratus, sodium carbonate, carragheen, Arabic gum, guar gum, pectin, sodium alginate, agar, microcrystalline cellulose, locust bean gum, ratio is arbitrary proportion.
4. according to the modulation breast that contains antarctic krill oil described in claim 1-3, it is characterized in that: described modulation breast contains emulsifying agent 0～0.3 mass parts, the mixture that is selected from sucrose acid fatty acid ester, mono-fatty acid glyceride, sorbose alcohol ester, soybean lecithin, lauric monoglyceride, methyl glycol fatty acid ester, ratio is arbitrary proportion.
5. according to the modulation breast that contains antarctic krill oil described in claim 1-4, it is characterized in that: described modulation breast contains sweetener 0～10 mass parts, be selected from the mixtures such as glucose, fructose, sucrose, maltose, lactose, Sucralose, acesulfame-K, saccharin sodium, antierythrite, xylitol, D-sorbite, mannitol, maltitol, hydroxyl isomaltulose, its ratio is arbitrary proportion.
6. according to the modulation breast that contains antarctic krill oil described in claim 1-5; it is characterized in that: institute tell modulation breast also contain other nutrient 0～1 mass parts; be selected from the mixture in vitamin A, vitamin D, Taurine, FOS, galactooligosaccharide, oligoisomaltose, lutein, lutein ester, beta carotene, sterol, sterol ester, mineral salt, its ratio is arbitrary proportion.
7. according to the modulation breast that contains antarctic krill oil described in claim 1-5, it is characterized in that: institute tells modulation breast and also contains flavoring essence 0～1 mass parts, and the flavoring essence of telling can be natural essence, natural equivalent essence or artificial essence.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410366020.0A CN104126666A (en) | 2014-03-26 | 2014-07-29 | Blended milk containing antarctic krill oil |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410116238.0 | 2014-03-26 | ||
| CN201410116238 | 2014-03-26 | ||
| CN201410366020.0A CN104126666A (en) | 2014-03-26 | 2014-07-29 | Blended milk containing antarctic krill oil |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104126666A true CN104126666A (en) | 2014-11-05 |
Family
ID=51799718
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410366020.0A Pending CN104126666A (en) | 2014-03-26 | 2014-07-29 | Blended milk containing antarctic krill oil |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104126666A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105412227A (en) * | 2015-12-02 | 2016-03-23 | 北京世纪合辉医药科技股份有限公司 | Unsaturated fatty acid dietary supplement and preparing method thereof |
| CN106922825A (en) * | 2017-04-07 | 2017-07-07 | 山东阳春羊奶乳业有限公司 | One kind modulation breast is stabilizing agent specially used and preparation method thereof |
| CN107567331A (en) * | 2015-03-31 | 2018-01-09 | 费森尤斯卡比德国有限公司 | Emulsion for parenteral |
| CN107897466A (en) * | 2017-11-09 | 2018-04-13 | 山东天地健生物工程有限公司 | A kind of antarctic krill oil interlayer type gel candy and preparation method thereof |
| CN109198339A (en) * | 2018-10-22 | 2019-01-15 | 辽渔南极磷虾科技发展有限公司 | A kind of krill fat beverage |
| CN110236198A (en) * | 2019-06-18 | 2019-09-17 | 宁波仙健海嘉生物科技有限公司 | Orally taken emulsion and preparation method thereof rich in Omega-3 unsaturated fatty acid |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102144669A (en) * | 2011-04-14 | 2011-08-10 | 内蒙古蒙牛乳业（集团）股份有限公司 | DHASCO (docosahexaenoic acid single cell oil)-contained modulated milk and production method thereof |
| CN103445186A (en) * | 2013-09-02 | 2013-12-18 | 青岛贝尔特生物科技有限公司 | Special marine albumen powder for infants and preparation method thereof |
| WO2014013335A2 (en) * | 2012-07-17 | 2014-01-23 | Aker Biomarine As | Concentration of omega-3 polyunsaturated fatty acids in krill oil |
-
2014
- 2014-07-29 CN CN201410366020.0A patent/CN104126666A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102144669A (en) * | 2011-04-14 | 2011-08-10 | 内蒙古蒙牛乳业（集团）股份有限公司 | DHASCO (docosahexaenoic acid single cell oil)-contained modulated milk and production method thereof |
| WO2014013335A2 (en) * | 2012-07-17 | 2014-01-23 | Aker Biomarine As | Concentration of omega-3 polyunsaturated fatty acids in krill oil |
| CN103445186A (en) * | 2013-09-02 | 2013-12-18 | 青岛贝尔特生物科技有限公司 | Special marine albumen powder for infants and preparation method thereof |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107567331A (en) * | 2015-03-31 | 2018-01-09 | 费森尤斯卡比德国有限公司 | Emulsion for parenteral |
| CN105412227A (en) * | 2015-12-02 | 2016-03-23 | 北京世纪合辉医药科技股份有限公司 | Unsaturated fatty acid dietary supplement and preparing method thereof |
| CN106922825A (en) * | 2017-04-07 | 2017-07-07 | 山东阳春羊奶乳业有限公司 | One kind modulation breast is stabilizing agent specially used and preparation method thereof |
| CN107897466A (en) * | 2017-11-09 | 2018-04-13 | 山东天地健生物工程有限公司 | A kind of antarctic krill oil interlayer type gel candy and preparation method thereof |
| CN109198339A (en) * | 2018-10-22 | 2019-01-15 | 辽渔南极磷虾科技发展有限公司 | A kind of krill fat beverage |
| CN110236198A (en) * | 2019-06-18 | 2019-09-17 | 宁波仙健海嘉生物科技有限公司 | Orally taken emulsion and preparation method thereof rich in Omega-3 unsaturated fatty acid |
| CN110236198B (en) * | 2019-06-18 | 2024-02-09 | 宁波仙健海嘉生物科技有限公司 | Oral emulsion rich in Omega-3 unsaturated fatty acid and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4699901B2 (en) | Dietary additive with body fat metabolism function and combustion energy utilization function | |
| CN104126666A (en) | Blended milk containing antarctic krill oil | |
| ES2763958T3 (en) | Oligosaccharides from human milk to improve stress symptoms | |
| ES2682074T3 (en) | Infant formulas containing docosahexaenoic acid and lutein | |
| ES2875458T3 (en) | Nutritional product for use in reducing the incidence of necrotizing enterocolitis in an infant, young child, or child | |
| ES2660416T3 (en) | Blend of lipids for baby nutrition | |
| JPH08205832A (en) | Enriched fruit juice | |
| RU2706963C2 (en) | Milk mixture containing breast milk oligosaccharides, polyunsaturated fatty acids, nucleotides and lutein | |
| US20180133190A1 (en) | Monoacylglycerols and fat-soluble nutrients for use in the treatment of nutrient deficiency from maldigestion | |
| CN104883909A (en) | Nutritional compositions containing a neurologic component and uses thereof | |
| CN107495379A (en) | Composition containing polyunsaturated fatty acid, protein and manganese and/or molybdenum | |
| JPH08205769A (en) | Strengthened or reinforced milk or milk induction product | |
| CN104427887A (en) | Nutritional compositions including rrr -alpha tocopherol and polyunsaturated fatty acids | |
| CN106061291A (en) | Methods for increasing skeletal muscle protein synthesis using green tea extract | |
| KR20180075716A (en) | Satiety-inducing composition | |
| WO2020237340A1 (en) | High-energy food supplement based on inverted sugars and ergogenic products for use in physical activity and method for producing same | |
| CN114222568A (en) | Very long chain fatty acids for treatment and alleviation of disease | |
| CN104757535A (en) | Lycium ruthenicum slimming tablet (tea) | |
| KR20110119305A (en) | A functional beverage comprising taurine, royal jelly, red ginseng, lycii fructus, glumate and apple essence as main ingredients | |
| Begum | A textbook of foods, Nutrition & Dietetics | |
| Pham-Huy et al. | Food and Lifestyle in Health and Disease | |
| JP2009269865A (en) | Oral administration agent | |
| JP2009269864A (en) | Agent for increasing phospholipid-bound arachidonic acid | |
| TW201929849A (en) | Composition for suppressing muscle mass reduction in cancer patients | |
| Hazra et al. | Ghee as medicine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20141105 |